Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia

European Heart Journal

Volumn 28, Issue 3, 2007, Pages 299-304

  Souverein, Olga W ^a   Defesche, Joep C ^a   Zwinderman, Aeilko H ^a   Kastelein, John J P ^a   Tanck, Michael W T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Age of onset; Cardiovascular disease; Familial hypercholesterolaemia; Frailty model; LDL receptor mutations

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COVARIANCE; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC RISK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; RECEPTOR GENE; RETROSPECTIVE STUDY; SMOKING; SURVIVAL TIME;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; MUTATION; RECEPTORS, LDL; RETROSPECTIVE STUDIES;

EID: 33846979779     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl366     Document Type: Article

References (34)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. The Metabolic & Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001. p2863-2913.
2. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991;303:893-896.
3. Villeger L, Abifadel M, Allard D, Rabes JP, Thiart R, Kotze MJ, Beroud C, Junien C, Boileau C, Varret M. The UMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 2002;20:81-87.
4. Heath KE, Gahan M, Whittall RA, Humphries SE. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. Atherosclerosis 2001;154:243-246.
5. Fouchier SW, Kastelein JJ, Defesche JC. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat 2005;26:550-556.
6. Graham CA, McClean E, Ward AJ, Beattie ED, Martin S, O'Kane M, Young IS, Nicholls DP. Mutation screening and genotype:phenotype correlation in familial hypercholesterolaemia. Atherosclerosis 1999;147:309-316.
7. Torres AL, Moorjani S, Vohl MC, Gagne C, Lamarche B, Brun LD, Lupien PJ, Despres JP. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations. Atherosclerosis 1996;126:163-171.
8. Gudnason V, Day IN, Humphries SE. Effect on plasma lipid levels of different classes of mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia. Arterioscler Thromb 1994;14:1717-1722.
9. Real JT, Chaves FJ, Ejarque I, Garcia-Garcia AB, Valldecabres C, Ascaso JF, Armengod ME, Carmena R. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population. Eur J Hum Genet 2003;11:959-965.
10. Umans-Eckenhausen MA, Sijbrands EJ, Kastelein JJ, Defesche JC. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002;106:3031-3036.
11. Betard C, Kessling AM, Roy M, Davignon J. Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene defect. Atherosclerosis 1996;119:43-55.
12. Bertolini S, Cantafora A, Averna M, Cortese C, Motti C, Martini S, Pes G, Postiglione A, Stefanutti C, Blotta I, Pisciotta L, Rolleri M, Langheim S, Ghisellini M, Rabbone I, Calandra S. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol 2000;20:E41-E52.
13. Gaudet D, Vohl MC, Couture P, Moorjani S, Tremblay G, Perron P, Gagne C, Despres JP. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men. Atherosclerosis 1999;143:153-161.
14. Vohl MC, Gaudet D, Moorjani S, Tremblay G, Perron P, Gagne C, Lesiege D, Bergeron J, Lupien PJ, Despres JP. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia. Eur J Clin Invest 1997;27:366-373.
15. Sun XM, Patel DD, Knight BL, Soutar AK. Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group. Atherosclerosis 1998;136:175-185.
16. Moorjani S, Roy M, Torres A, Betard C, Gagne c, Lambert M, Brun D, Davignon J, Lupien P. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet 1993;341:1303- 1306.
17. Sijbrands EJ, Lombardi MP, Westendorp RG, Leuven JA, Meinders AE, der Laarse AV, Frants RR, Havekes LM, Smelt AH. Similar response to simvastatin in patients heterozygous for familial hypercholesterolemia with mRNA negative and mRNA positive mutations. Atherosclerosis 1998;136:247-254.
18. Sijbrands EJ, Westendorp RG, Paola LM, Havekes LM, Frants RR, Kastelein JJ, Smelt AH. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis 2000;149:421-425.
19. Chaves FJ, Real JT, Garcia-Garcia AB, Civera M, Armengod ME, Ascaso JF, Carmena R. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. J Clin Endocrinol Metab 2001;86:4926-4932.
20. Klein JP, Moeschberger ML. Survival Analysis Techniques for Censored and Truncated Data. New York: Springer-Verlag; 1997.
21. Jansen ACM, van Aalst-Cohen ES, Tanck MW, Trip MD, Lansberg PJ, Liem AH, van Lennep HWOR, Sijbrands EJG, Kastelein JJP. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med 2004;256:482-490.
22. Fouchier SW, Defesche JC, Umans-Eckenhausen MW, Kastelein JJ. The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet 2001;109:602-615.
23. Damgaard D, Nissen PH, Jensen LG, Nielsen GG, Stenderup A, Larsen ML, Faergeman O. Detection of large deletions in the LDL receptor gene with quantitative PCR methods. BMC Med Genet 2005;6:15.
24. Wang J, Ban MR, Hegele RA. Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia. J Lipid Res 2005;46:366-372.
25. Holla OL, Teie C, Berge KE, Leren TP. Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA. Clin Chim Acta 2005;356:164-171.
26. Antonarakis SE, the Nomenclature Working Group. Recommendation for a nomenclature system for human gene mutations. Hum Mutat 1998;11:1-3.
27. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12.
28. Castillo S, Reyes G, Tejedor D, Mozas P, Suarez Y, Lasuncion MA, Cenarro A, Civeira F, Alonso R, Mata P, Pocovi M. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels cardiovascular disease. Hum Mutat 2002;20:477.
29. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992;1:445-466.
30. Lombardi P, Sijbrands EJ, van de Giessen K, Smelt AH, Kastelein JJ, Frants RR, Havekes LM. Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. J Lipid Res 1995;36:860- 867.
31. AustinMA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004;160:421-429.
32. Sijbrands EJ, Westendorp RG, Defesche JC, de Meier PH, Smelt AH, Kastelein JJ. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001;322:1019-1023.
33. Ferrieres J, Lambert J, Lussier-Cacan S, Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same ldl receptor gene mutation. Circulation 1995;92:290-295.
34. Pimstone SN, Sun XM, du Souich C, Frohlich JJ, Hayden MR, Soutar AK. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler Thromb Vasc Biol 1998;18:309- 315.